Healthware, a healthcare agency, consultancy, and digital health group headquartered in Italy, together with the Digital Therapeutics Alliance, a nonprofit organisation based in Virginia dedicated to promoting digital therapeutic adoption, have jointly announced a report, outlining policy pathways for digital health adoption in Europe.
In June 2022, Healthware collaborated with the Digital Therapeutics Alliance as a knowledge partner for the development of digital therapeutics (DTx) policies in Europe. As part of this collaboration, they established a DTx policy coalition to engage various stakeholders and foster discussions on evolving scenarios, needs, and potential opportunities. The coalition aimed to provide clarity, inform policy scalability, and promote equitable access to digital therapeutics.
In June 2023, during the DTA Summit, a dedicated website will be launched called dtxpolicylandscape.org. The website serves as a resource, offering information and clarity on the evolving landscape of digital therapeutics, particularly focusing on policies, fit-for-purpose appraisal criteria, and reimbursement pathways.
The website's first significant contribution is a report that provides a comprehensive analysis of the evolving DTx policy pathways in Europe. It includes a mapping of countries that have already defined appraisal criteria and access and reimbursement pathways for digital therapeutics, taking into account their unique digital nature. Additionally, the report incorporates insights on how the scenarios have been evolving, gathered through engagements with stakeholders, policymakers, and leaders from various countries throughout the year.
The report focuses on Europe and aims to present a snapshot of the current state of affairs while acknowledging the dynamic nature of the field. It highlights emerging trends and converging patterns that can inform scalable approaches to DTx policies, despite the fragmented and often country-specific nature of their development.
Click here to read the original news story.